MAL2 and breast carcinoma: We did not see significant correlation (AUC < 0.6, Mann–Whitney test p-value < 0.05) between high levels of gene expression and breast cancer patients’ poor response to chemotherapy for any of the other SE-associated genes analyzed (including MAL2) when analyzing the entire database or when focusing on Grade III breast cancer (Table S3).